EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
| Market Cap (Intraday) | 834.66M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $17.99 |
| 50-Day MA | $22.62 |
| 200-Day MA | $16.19 |
EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT
480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 121
Description
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.